Department of Pathology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Department of Pathology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning, China.
Front Immunol. 2024 Mar 12;15:1335473. doi: 10.3389/fimmu.2024.1335473. eCollection 2024.
Differentiated embryo-chondrocyte expressed gene 2 (DEC2) is a member of the basic helix-loop-helix (bHLH) subfamily of transcription factors. DEC2 is implicated in tumor immunotherapy, immune system function regulation, and autoimmune diseases. DEC2 enhances Th2 cell differentiation by regulating the IL-2 and IL-4 signaling pathways and mediates the growth of B-1a cells, thereby promoting the occurrence and development of inflammatory responses. In this study, we review the reported roles of DEC2, including the regulation of immune cell differentiation and cytokine production in various cells in humans, and discuss its potential in treating autoimmune diseases and tumors.
分化胚胎-软骨细胞表达基因 2 (DEC2) 是转录因子碱性螺旋-环-螺旋 (bHLH) 亚家族的成员。DEC2 参与肿瘤免疫治疗、免疫系统功能调节和自身免疫性疾病。DEC2 通过调节 IL-2 和 IL-4 信号通路增强 Th2 细胞分化,并介导 B-1a 细胞的生长,从而促进炎症反应的发生和发展。在本研究中,我们综述了 DEC2 的报道作用,包括其在人类各种细胞中对免疫细胞分化和细胞因子产生的调节作用,并讨论了其在治疗自身免疫性疾病和肿瘤方面的潜力。